Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olusegun Adekanle is active.

Publication


Featured researches published by Olusegun Adekanle.


PLOS ONE | 2015

Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks

Opaleye O. Oluyinka; Hoang Van Tong; Sy Bui Tien; Ademola Hezekiah Fagbami; Olusegun Adekanle; Olusola Ojurongbe; C.-Thomas Bock; Peter G. Kremsner; Thirumalaisamy P. Velavan

Background Occult hepatitis B virus infection (OBI) characterized by the absence of detectable HBsAg remains a potential threat in blood safety. We investigated the actual prevalence, viral factors and genotype of OBI infections in Nigerian blood donors. Methods Serum collected from two blood banks were reconfirmed as HBsAg seronegative by ELISA. Forty HBsAg positive samples were employed as controls. HBV-DNA was amplified from all donors and viral loads were determined using quantitative real-time PCR. Antibodies to the HBV core, surface and HBe antigen (anti-HBc,anti-HBs,HBeAg) were measured. The PreS/S and PreC/C regions of the HBV genome were sequenced. Results Of the 429 blood donors, 72(17%) were confirmed as OBI by DNA detection in different reference labs and excluded the concern of possible contamination. Of the 72 OBI samples, 48(67%) were positive for anti-HBc, 25(35%) positive for anti-HBs, and 2(3%) positive for HBeAg. Of the 72 OBI samples, 31(43%) were seropositive for either anti-HBc, anti-HBs or HBeAg, 21 (30%) positive for both anti-HBc and anti-HBs,one positive for both anti-HBc and HBeAg. None of the OBI samples were positive for all three serological markers. The viral load was <50copies/ml in the OBI samples and genotype E was predominant. The L217R polymorphism in the reverse transcriptase domain of the HBV polymerase gene was observed significantly higher in OBI compared with HBsAg positive individuals (P<0.0001). Conclusion High incidence of OBI is relevant in high endemic areas worldwide and is a general burden in blood safety. This study signifies the high prevalence of OBI and proposes blood donor samples in Nigeria should be pre-tested for OBI by nucleic acid testing (NAT) and/or anti-HBc prior to transfusion to minimize the HBV infection risk.


PLOS ONE | 2017

Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile

Ute Harrison; Muinah A Fowora; Abiodun T. Seriki; Eva Loell; Susanna Mueller; Margaret Ugo-Ijeh; Charles A. Onyekwere; Olufunmilayo A. Lesi; Jesse A. Otegbayo; Adegboyega Akere; Dennis A. Ndububa; Olusegun Adekanle; Ebere Anomneze; Fatimah B Abdulkareem; Isaac Adeleye; Alexander Crispin; Gabriele Rieder; Wolfgang B. Fischer; Stella I. Smith; Rainer Haas

Antibiotic resistance in Helicobacter pylori is a factor preventing its successful eradication. Particularly in developing countries, resistance against commonly used antibiotics is widespread. Here, we present an epidemiological study from Nigeria with 111 isolates. We analyzed the associated disease outcome, and performed a detailed characterization of these isolated strains with respect to their antibiotic susceptibility and their virulence characteristics. Furthermore, statistical analysis was performed on microbiological data as well as patient information and the results of the gastroenterological examination. We found that the variability concerning the production of virulence factors between strains was minimal, with 96.4% of isolates being CagA-positive and 92.8% producing detectable VacA levels. In addition, high frequency of bacterial resistance was observed for metronidazole (99.1%), followed by amoxicillin (33.3%), clarithromycin (14.4%) and tetracycline (4.5%). In conclusion, this study indicated that the infection rate of H. pylori infection within the cohort in the present study was surprisingly low (36.6%). Furthermore, an average gastric pathology was observed by histological grading and bacterial isolates showed a uniform pathogenicity profile while indicating divergent antibiotic resistance rates.


Annals of African Medicine | 2014

Assessment of the sexual functions of males with chronic liver disease in South West Nigeria

Olusegun Adekanle; Dennis A. Ndububa; E. O. Orji; Oluwasegun Ijarotimi

BACKGROUND Patients with chronic liver disease (CLD) have been reported to have sexual dysfunction irrespective of etiology. There is little or no report from Nigeria on this disorder. This study looked at sexual dysfunction among male patients with CLD. MATERIALS AND METHODS Patients with chronic viral hepatitis B, liver cirrhosis (LC) and hepatocellular carcinoma (HCC) were interviewed using the international index of erectile function questionnaire. Their responses were compared with an age and sex matched healthy controls. Bio-data and body mass index were obtained for both groups and liver disease severity was graded for patients using the Child-Pugh score. Analysis was done using SPSS (SPSS Inc., Chicago, IL, USA, 2004) for frequencies and means while comparison of means was done using Students t-test. Significance level was put at P < 0.05. RESULTS There were 120 subjects consisting of 60 patients aged from 28 to 71 years; mean (SD) 45. 3 ± 9.4 and 60 controls aged from 29 to 79 years with mean (SD) 45.5 ± 10.1 years. Sexual dysfunctions were seen in patients with HCC and LC in the domains of sexual desire and sexual satisfaction respectively when compared with controls. When patients were divided into the various liver disease severities, patients in Child-Pugh Grade B scored low in the domain of arousal, whereas the domains of erectile functions, orgasm, resolution and satisfaction were affected in patients in Grade C when compared with controls. CONCLUSIONS Male patients with CLD have significant sexual dysfunctions when compared with controls. The dysfunctions are more pronounced in those with Grade C liver disease. Sexual concerns of CLD should be inquired of in those with advanced liver disease.


Annals of African Medicine | 2012

Cognitive functions in patients with liver cirrhosis: assessment using community screening interview for dementia.

Olusegun Adekanle; Taofiki Sunmonu; Morenikeji Komolafe; Dennis A. Ndububa

INTRODUCTION Neurocognitive dysfunction is common in patients with liver cirrhosis who have no evidence of overt hepatic encephalopathy and is usually associated with impairment of activities of daily living in the patients. MATERIALS AND METHODS Forty patients with liver cirrhosis without overt hepatic encephalopathy were studied along with forty-one healthy controls. Blood samples were taken from the patients for liver function tests and Hepatitis B and C screening. Liver disease severity was graded using the Child-Pugh scoring system. Community Screening Interview for the Dementia (CSID) questionnaire was administered to all subjects. The CSID questionnaire assesses the cognitive functions of the subjects in the domains of language, memory, orientation, attention/calculation, and praxis. The data were collated and analyzed with the aid of SPSS 15.0 software for frequency, means, and comparison of means using Students t-test and one-way ANOVA. Significant level was put at P< 0.05. RESULTS The mean age ± SD of the patients was 46.15 ± 15.31 years and the controls was 45.66 ± 11.54 years. There were 30 males and 10 females in the patients group while the control had has 26 males and 15 females. Majority of the patients had secondary level of education. Nine out of 40 patients (23%) had abnormally low total CSID score. The patients with liver cirrhosis performed poorly in the domains of language, memory, attention/calculation, and praxis. There was no difference in the orientation scores between the patients and the normal controls. The type of Hepatitis virus infection, serum liver enzyme, serum albumin, serum bilirubin, prothrombin time and Child Pugh class of the patients did not influence cognitive performance in the patients. CONCLUSION Patients with liver cirrhosis have significant cognitive impairment compared with controls and liver function tests/ clinical parameters in the patients did not correlate with their cognitive functions.


Asian Pacific Journal of Cancer Prevention | 2018

Clinical and Socio- Demographic Risk Factors for Acquisition of Helicobacter pylori Infection in Nigeria

Stella I. Smith; Tolu Jolaiya; Muinah A Fowora; Pia Palamides; Favour Ngoka; Moses Bamidele; Olufunmilayo A. Lesi; Charles A. Onyekwere; Rose Ugiagbe; Ifeanyi Agbo; Dennis A. Ndububa; Olusegun Adekanle; Abimbola M. Adedeji; Isaac Adeleye; Ute Harrison

Background The aim of the study was to assess clinical and socio-demographic characteristics as well as prior drug usage as risk factors for Helicobacter pylori (H. pylori) infection in Nigeria. Methods A total of 347 respondents were surveyed by assessing their clinical and socio-demographic characteristics in comparison with the non-invasive gold standard for H. pylori diagnosis, the urea breath test (UBT). Chi-square test and odds ratio analyses were conducted in order to assess if variables such as socio-demographic factors, drug intake, and history of ulcer/gastritis/gastric cancer within the family significantly predicted test results. Results A total of 130 (37.5%) respondents were positive for H. pylori by the UBT. Living with more than three people in an apartment and a history of ulcer/gastritis within the family were significantly associated with H. pylori (p ≤0.05), as well as current antibiotic intake (p ≤0.05). Nationality, stay outside Nigeria, level of education, main occupation, smoking and drinking habits, sources of drinking water, number of children and history of gastric cancer had no significant association with H. pylori infection (p ≥ 0.05). Conclusion The results of the questionnaire revealed that most socio-demographic characteristics of the respondents had no significant association with H. pylori. Overcrowding, having siblings/parents with history of ulcer/gastritis as well as prior antibiotic usage had a significant association.


Nigerian Journal of Clinical Practice | 2017

Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma

Akpakip Ikpong Ette; Dennis A. Ndububa; Olusegun Adekanle; Udeme Ekrikpo

Background: Alpha-fetoprotein (AFP) and Des-gamma-carboxyprothrombin (DCP) have been extensively studied as biomarkers for the diagnosis of and prognostication in hepatocellular carcinoma (HCC). However there are only few reports on the clinical characteristics of hepatocellular carcinoma in relation to the combination of the two tumor markers in hepatitis B virus-related HCC. Aim: The aim of this study was to investigate the clinical characteristics of HBV-related HCC in relation to different sets of AFP and DCP values. Methods: Sixty-two patients with untreated HCC were studied. The positive value of AFP was set at 20 1U/L while DCP positive value was set at 150 mAU/ml. Patients were divided into three groups: Group 1(n=36) with AFP ≥ 20 IU/L and DCP ≥ 150 mAU/ml. Group 2(n=24) with AFP <20 1U/L and DCP ≥ 150 mAU/ml. Group 3 (n=2) with AFP < 20 1U/L and DCP < 150 mAU/ml. There were no patients in group 4 meant for those with AFP ≥ 20 1U/L and DCP < 150 mAU/ml. Clinical and laboratory variables were compared among the groups. Results: Clinical and laboratory variables were comparable among the groups with the exception of gender and values of serum alanine aminotransferase (ALT). Males were significantly more than females among the groups (p<0.03). ALT values were significantly different among the groups (p<0.006). Paired comparisons between the groups showed the mean values of serum ALT were significantly higher in group 2 than in group 1(p<0.003). The mean serum ALT values were also higher in group 2 than in group 3 (p <0.014). There was no significant difference between group 1 and group 3 (P = 0.124). Conclusion: HCC patients who are sero-positive for DCP and sero-negative for AFP have significantly higher levels of serum ALT; serum ALT levels may be of diagnostic importance in AFP-negative, HBV-related HCC patients.


Hepatitis Research and Treatment | 2015

Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary Hospital

Olusegun Adekanle; Dennis A. Ndububa; Samuel Anu Olowookere; Oluwasegun Ijarotimi; Kayode Thaddeus Ijadunola


Nigerian Journal of Clinical Practice | 2010

The contribution of alcohol to chronic liver disease in patients from South-West Nigeria

Dennis A. Ndububa; Os Ojo; Va Adetiloye; Ao Aladegbaiye; Rasaaq A Adebayo; Olusegun Adekanle


West African journal of medicine | 2005

Chronic hepatitis in Nigerian patients: a study of 70 biopsy-proven cases.

Dennis A. Ndububa; Os Ojo; Va Adetiloye; Ma Durosinmi; Olasode Bj; Oc Famurewa; Ao Aladegbaiye; Olusegun Adekanle


Arab Journal of Gastroenterology | 2012

Cognitive function in patients with liver cirrhosis without overt hepatic encephalopathy: assessment using an automated neuropsychological test battery.

Taofiki Sunmonu; Olusegun Adekanle; Morenikeji Komolafe; Dennis A. Ndububa

Collaboration


Dive into the Olusegun Adekanle's collaboration.

Top Co-Authors

Avatar

Dennis A. Ndububa

Obafemi Awolowo University

View shared research outputs
Top Co-Authors

Avatar

Ao Aladegbaiye

Obafemi Awolowo University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Muinah A Fowora

Nigerian Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Olasode Bj

Obafemi Awolowo University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Os Ojo

Obafemi Awolowo University

View shared research outputs
Top Co-Authors

Avatar

Stella I. Smith

Nigerian Institute of Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge